Healthcare
Genesis acquires Home Care Promedica
GP is investing from its Genesis Growth Equity Fund I, a vehicle that held a first close on €31m in 2019
NPM Capital's Bergman Clinics buys Van Linschoten Specialisten
Add-on comes after Mergermarket reported that the sale of Bergman had been suspended in March 2020
Cowen leads $60.8m round for F2G
Existing investors Novo Holdings, Morningside Ventures and Brace Pharma Capital also participate
Occident leads CHF 5.1m series-A for Hemotune
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
VCs sell stakes in Kandy Therapeutics to Bayer
Backers included Advent Life Sciences, Fountain Healthcare Partners, Forbion, OrbiMed and Longitude
Panakes et al. in €20m series-B for InnovHeart
Indaco Venture and CDP Venture Capital also take part in the round, alongside previous backer Genextra
DvH Ventures launches Digital Health Fund
Dieter von Holtzbrinck Ventures (DvH Ventures) has announced the launch of its first Digital Health fund, which has held a first close on €60m.
Rigeto Unternehmerkapital acquires Oehm & Rehbein
Acquisition of Germany-based x-ray equipment and software was backed by senior debt from ApoBank
Versant Ventures invests $30m in Matterhorn Biosciences
Versant has launched the T-cell therapy developer in partnership with the University of Basel
Versant and RA lead €66m round for T-knife
Andera Partners and Boehringer Ingelheim Venture Fund also backed the T-cell therapy developer
G Square looking to exit ISPS - report
G Square acquired the healthcare training business from Montefiore in 2016
KKR, Ardian buy Elsan stake from CVC
With the support of its new investors, the company plans to deploy around €150m per year to boost innovation
Stanley Capital acquires Noden Pharma DAC
Stanley Capital expects to pursue a buy-and-build strategy with the pharmaceutical company
PAI to acquire Amplitude from Apax
Apax, which currently owns 41.4% of the listed company, would fully exit its stake
Fund+ leads €23m series-A for Exevir
Exevir will commit to the international effort to pursue new treatment for Covid-19
Life Science Partners et. al in series-A round for Vico Therapeutics
Biotech startup will use the proceeds to further advance its therapy
Eurazeo China Acceleration Fund invests €80m in DORC
This is the first deal made by the fund, which targets companies with high-growth potential in the Chinese market
Consortium in $60m series-B for Withings
Withings plans to add 100 new positions in the US and France by the end of the year to strengthen its teams
Sofinnova, AbbVie lead €28m series-A for Enthera
Indaco Venture Partners, JDRF T1D Fund and several Italian investors also take part in the round
IK sells Aposan to Ardian-backed Santé Cie
Sale ends an investment period of almost four years, during which revenues and EBITDA doubled
Advent France Biotechnology, Invivo invest €4.25m in Arthex
Company intends to use the fresh capital to advance the development of its myotonic dystrophy therapy
Fund+ leads €38m series-B for Indigo Diabetes
Jan Van den Bossche, partner at Fund+, will join the board of the company
Capiton buys CNP Group
Acquisition of the pharmaceutical company marks the first deal from Capiton's sixth fund
QIA et al. invest $162m in CureVac
mRNA vaccine developer is valued at $1.6bn and also secured backing from the KfW and GlaxoSmithKline